Published in Nature on March 21, 1996
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med (2009) 4.11
Toxin-induced models of Parkinson's disease. NeuroRx (2005) 2.67
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol (2004) 2.12
Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.86
Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx (2004) 1.77
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet (2000) 1.61
Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF. Exp Neurol (2013) 1.40
Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One (2007) 1.38
Treatment of Parkinson's disease with trophic factors. Neurotherapeutics (2008) 1.35
Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci (2008) 1.29
Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci U S A (1997) 1.28
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A (1997) 1.26
Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet (2011) 1.22
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res (2005) 1.15
Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron (2000) 1.14
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1997) 1.14
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci U S A (1997) 1.10
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08
Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol Ther (2010) 1.07
Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol Ther (2011) 1.06
Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways. PLoS One (2012) 1.01
Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS One (2009) 1.00
GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling. PLoS One (2009) 0.99
Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease. PLoS One (2011) 0.99
NURR1 in Parkinson disease--from pathogenesis to therapeutic potential. Nat Rev Neurol (2013) 0.98
Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion. J Clin Immunol (2007) 0.96
The promise of neuroprotective agents in Parkinson's disease. Front Neurol (2011) 0.96
Large animal models of neurological disorders for gene therapy. ILAR J (2009) 0.95
Intraputamenal infusion of exogenous neurturin protein restores motor and dopaminergic function in the globus pallidus of MPTP-lesioned rhesus monkeys. Cell Transplant (2008) 0.95
TGFbeta induces GDNF responsiveness in neurons by recruitment of GFRalpha1 to the plasma membrane. J Cell Biol (2002) 0.95
Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor. Proc Natl Acad Sci U S A (1998) 0.94
Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease. Curr Neuropharmacol (2007) 0.94
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brain. Neurobiol Dis (2011) 0.93
Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo. J Cereb Blood Flow Metab (2015) 0.92
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J Comp Neurol (2009) 0.92
Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat (2010) 0.92
Role of glial cells in neurotoxin-induced animal models of Parkinson's disease. Neurol Sci (2010) 0.92
GDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse model. PLoS One (2014) 0.91
Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease. Brain Behav (2013) 0.91
Ultrastructural localization and function of dopamine D1-like receptors in the substantia nigra pars reticulata and the internal segment of the globus pallidus of parkinsonian monkeys. Eur J Neurosci (2010) 0.91
GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors. J Neurochem (2009) 0.90
The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model. Evid Based Complement Alternat Med (2012) 0.89
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases. J Neurochem (2010) 0.89
GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease. Front Neuroanat (2015) 0.87
Ret rescues mitochondrial morphology and muscle degeneration of Drosophila Pink1 mutants. EMBO J (2014) 0.87
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete? J Comp Neurol (2014) 0.86
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors. Front Cell Neurosci (2013) 0.86
Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression. Mol Cell Biol (2009) 0.86
A dual-hit animal model for age-related parkinsonism. Prog Neurobiol (2009) 0.85
Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Exp Brain Res (2003) 0.85
The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease. Curr Top Med Chem (2009) 0.85
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity. Mol Neurobiol (2013) 0.85
Neurorestoration. Parkinsonism Relat Disord (2012) 0.85
Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders. Exp Neurol (2010) 0.85
Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging (2010) 0.85
Cell-based therapies for Parkinson's disease: past, present, and future. Antioxid Redox Signal (2009) 0.85
Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int J Cell Biol (2013) 0.85
Development of a stable, early stage unilateral model of Parkinson's disease in middle-aged rhesus monkeys. Exp Neurol (2008) 0.85
A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys. PLoS One (2012) 0.84
Tetanus toxin C-fragment: the courier and the cure? Toxins (Basel) (2010) 0.84
Pathways towards an effective immunotherapy for Parkinson's disease. Expert Rev Neurother (2011) 0.84
Activated microglia provide a neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-α secretion after subacute cerebral ischemia. Int J Mol Med (2012) 0.84
Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain. Neurobiol Aging (2014) 0.83
1alpha,25-Dihydroxyvitamin D(3) Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation. J Clin Neurol (2006) 0.83
Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats. Neuroscience (2009) 0.83
Dopamine neuron stimulating actions of a GDNF propeptide. PLoS One (2010) 0.83
Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J Neural Transm (Vienna) (2001) 0.83
Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age. Brain Res Bull (2005) 0.83
Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase. J Biol Chem (2010) 0.82
Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study. J Neurol Neurosurg Psychiatry (2007) 0.82
Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J Comp Neurol (2005) 0.81
GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease. Neurosci Lett (2006) 0.81
Preclinical assessment of stem cell therapies for neurological diseases. ILAR J (2009) 0.81
Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain. Neuropharmacology (2010) 0.81
Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res (2008) 0.81
Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys. Cell Transplant (2008) 0.81
Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease. Neuroscience (2013) 0.81
Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol Neurobiol (2009) 0.81
ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion. J Neurochem (2014) 0.81
Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease. Behav Brain Res (2011) 0.80
Human umbilical cord mesenchymal stem cells infected with adenovirus expressing HGF promote regeneration of damaged neuron cells in a Parkinson's disease model. Biomed Res Int (2014) 0.80
Gene therapy: a viable therapeutic strategy for Parkinson's disease? J Neurol (2010) 0.80
Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease. PLoS One (2016) 0.79
Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity. J Neuroimmunol (2010) 0.79
Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence. Neuropeptides (2011) 0.79
Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency. Brain Res (2014) 0.79
Postnatal development of neurons, interneurons and glial cells in the substantia nigra of mice. Cell Mol Neurobiol (2010) 0.78
The neurogenic niche in the carotid body and its applicability to antiparkinsonian cell therapy. J Neural Transm (Vienna) (2009) 0.78
Neuropharmacologic Approaches to Restore the Brain's Microenvironment. J Neuroimmune Pharmacol (2016) 0.78
Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats. Stem Cells Transl Med (2014) 0.78
Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease. Sci Rep (2016) 0.78
Increased glial-derived neurotrophic factor in the small intestine of rats infected with the tapeworm, Hymenolepis diminuta. Int J Exp Pathol (2008) 0.77
Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys. Sci Rep (2013) 0.77
Globus pallidus plays a critical role in neurotrophic factor induced functional improvements in hemiparkinsonian monkeys. Biochem Biophys Res Commun (2008) 0.77
Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress. J Psychiatry Neurosci (2014) 0.77
Improved methods for electroacupuncture and electromyographic recordings in normal and parkinsonian rhesus monkeys. J Neurosci Methods (2010) 0.77
Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides (2014) 0.77
Sorting protein-related receptor SorLA controls regulated secretion of glial cell line-derived neurotrophic factor. J Biol Chem (2011) 0.77
Genetic manipulation for inherited neurodegenerative diseases: myth or reality? Br J Ophthalmol (2016) 0.77
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res (1998) 22.69
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
PipMaker--a web server for aligning two genomic DNA sequences. Genome Res (2000) 17.46
Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol (1997) 15.19
Effects of the obese gene product on body weight regulation in ob/ob mice. Science (1995) 13.57
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell (1996) 10.40
Sox9 is required for cartilage formation. Nat Genet (1999) 7.89
Comparison of DNA sequences with protein sequences. Genomics (1997) 7.76
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med (1996) 7.06
Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess (1999) 7.00
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
The revised UCLA Loneliness Scale: concurrent and discriminant validity evidence. J Pers Soc Psychol (1980) 6.07
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA. Science (1969) 4.81
Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science (2000) 4.61
Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci U S A (1968) 4.24
Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A (2001) 4.13
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell (1990) 4.12
The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell (2001) 4.11
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
Deprivation payments to general practitioners: limitations of census data. BMJ (1996) 3.98
Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol. J Natl Cancer Inst (2001) 3.88
The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol (2003) 3.83
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res (1998) 3.80
Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ (2006) 3.77
Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol (1994) 3.66
Using data from the 1991 census. BMJ (1995) 3.63
Expectations and high school change: teacher-researcher collaboration to prevent school failure. Am J Community Psychol (1991) 3.62
Dachshund and eyes absent proteins form a complex and function synergistically to induce ectopic eye development in Drosophila. Cell (1997) 3.58
Guidelines on the management of common bile duct stones (CBDS). Gut (2008) 3.58
Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature (2001) 3.42
Early predictors of career achievement in academic medicine. JAMA (1992) 3.35
Primary and preschool immunisation in Grampian: progress and the 1990 contract. BMJ (1992) 3.26
Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis (2000) 3.20
Electron microscopy of size and shape of viral DNA in solutions of different ionic strengths. J Mol Biol (1967) 3.16
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Source-zone characterization of a chlorinated-solvent contaminated Superfund site in Tucson, AZ. J Contam Hydrol (2006) 3.10
A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol Cell Biol (2000) 3.04
A prospective study of delirium in hospitalized elderly. JAMA (1990) 3.02
The actinomycete Thermobispora bispora contains two distinct types of transcriptionally active 16S rRNA genes. J Bacteriol (1997) 2.96
The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health (2004) 2.92
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet (1998) 2.90
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol (2000) 2.81
The use of multiple imputation for the analysis of missing data. Psychol Methods (2001) 2.76
Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev Sci Tech (2002) 2.76
Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem (2000) 2.73
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
Distinct types of rRNA operons exist in the genome of the actinomycete Thermomonospora chromogena and evidence for horizontal transfer of an entire rRNA operon. J Bacteriol (1999) 2.72
Kinesin family in murine central nervous system. J Cell Biol (1992) 2.70
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function. Oncogene (2007) 2.68
The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med Decis Making (2000) 2.68
beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci U S A (1999) 2.66
Measuring performance to drive improvement: development of a clinical indicator set for general medicine. Intern Med J (2009) 2.66
Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry. J Mass Spectrom (1997) 2.54
Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol (2001) 2.52
Seasonal, regional and secular variations of cardiovascular and cerebrovascular mortality in New Zealand. Aust N Z J Med (1990) 2.51
Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol (1989) 2.50
CA 125: the past and the future. Int J Biol Markers (1999) 2.50
Postcodes and the 1991 census of population: issues, problems and prospects. Trans Inst Br Geogr (1992) 2.46
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Xa21D encodes a receptor-like molecule with a leucine-rich repeat domain that determines race-specific recognition and is subject to adaptive evolution. Plant Cell (1998) 2.43
On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39
Superfibronectin is a functionally distinct form of fibronectin. Nature (1994) 2.38
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling. Ann Oncol (2007) 2.34
Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J Bone Miner Res (1991) 2.33
The targeting of Lamp1 to lysosomes is dependent on the spacing of its cytoplasmic tail tyrosine sorting motif relative to the membrane. J Cell Biol (1996) 2.32
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet (2000) 2.26
Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr Opin Struct Biol (1999) 2.25
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol (2001) 2.24
New structural picture of the Ge2Sb2Te5 phase-change alloy. Phys Rev Lett (2011) 2.21
Bacterial resistance to silver in wound care. J Hosp Infect (2005) 2.14
Effect of discharge samples on duration of breast-feeding. Pediatrics (1992) 2.12
Hospital infant formula discharge packages. Do they affect the duration of breast-feeding? Arch Pediatr Adolesc Med (1997) 2.11
Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun (2013) 2.10
Is paediatrics safe in general practitioners' hands? A study in the north of England. J R Coll Gen Pract (1989) 2.08
Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med (1993) 2.07
Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci (2001) 2.07
Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis (1998) 2.07
Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab (2000) 2.06
Database of non-canonical base pairs found in known RNA structures. Nucleic Acids Res (2000) 2.06
MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A (2000) 2.04
Theaflavins in black tea and catechins in green tea are equally effective antioxidants. J Nutr (2001) 2.02
The psychometric properties of a tinnitus handicap questionnaire. Ear Hear (1990) 2.01
Test-based exact confidence intervals for the difference of two binomial proportions. Biometrics (1999) 2.01
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol (2004) 1.99
Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels. J Biol Chem (2001) 1.99
Difficulties in recognizing one's own incompetence: novice physicians who are unskilled and unaware of it. Acad Med (2001) 1.98
DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J (1996) 1.97
The running tie-over dressing. Plast Reconstr Surg (2000) 1.96